SCHEMBL24104666

SCHEMBL24104666

Cc1ccc(-c2cc(C3CCCCC3)c(C)cn2)cc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.40
ADORA2B P29275 2/20 0.40
ADORA1 P30542 2/20 0.40
ADORA2A P29274 1/20 0.40
PTGS2 P35354 1/20 0.38
ALOX5AP P20292 2/20 0.37
FEN1 P39748 2/20 0.37
CAMKK2 Q96RR4 7/20 0.37
CAMKK1 Q8N5S9 6/20 0.37
SGK1 O00141 1/20 0.37
AURKA O14965 1/20 0.37
SGK3 Q96BR1 1/20 0.37
SGK2 Q9HBY8 1/20 0.37
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
S1PR1 P21453 1/20 0.36
S1PR5 Q9H228 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24104183 0.90 S1PR1 (0.41) PTGS2ALOX5APFEN1CAMKK2CAMKK1
SCHEMBL18729486 0.87 LDHA (0.45) ADORA3ADORA2BADORA1ADORA2AALOX5AP
SCHEMBL22134625 0.86 ALOX5AP (0.39) ALOX5APFEN1CAMKK2CAMKK1SGK1
SCHEMBL22134627 0.85 S1PR1 (0.39) ADORA3ADORA2BADORA1ADORA2APTGS2
SCHEMBL25984574 0.85 ADORA3 (0.37) ADORA3ADORA2BADORA1ADORA2APTGS2
SCHEMBL26312977 0.82 FEN1 (0.38) ADORA1ADORA2APTGS2ALOX5APFEN1
SCHEMBL24066448 0.81 LDHA (0.46) ADORA3ADORA1ADORA2AALOX5APFEN1
SCHEMBL19434148 0.81 S1PR1 (0.46) ADORA3ADORA2BADORA1ADORA2AS1PR1
SCHEMBL30690079 0.81 S1PR1 (0.46) ADORA3ADORA2BADORA1ADORA2AS1PR1
SCHEMBL22134615 0.80 S1PR1 (0.41) ADORA3ADORA2BADORA1ADORA2ACAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 US disclosed
EP-3730506-B1 USE OF A HETEROLEPTIC COMPOUND AS AN EMITTER IN AN OLED UNIVERSAL DISPLAY CORP (US) 2021-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 ADORA3 3494/4885ADORA2B 3623/4885ADORA1 4421/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 ADORA3 3494/4885ADORA2B 3623/4885ADORA1 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.